We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRBS icon
3701
Blue Ridge Bankshares
BRBS
$323M
$128K ﹤0.01%
7,268
+5,841
+409% +$95.9K
CRUS icon
3702
CALL
Cirrus Logic
CRUS
$6.42B
$128K ﹤0.01%
1,500
UDOW icon
3703
ProShares UltraPro Dow 30
UDOW
$885M
$128K ﹤0.01%
+3,494
New +$124K
UMH
3704
UMH Properties
UMH
$1.3B
$128K ﹤0.01%
5,850
-59,098
-91% -$1.26M
AEP icon
3705
PUT
American Electric Power
AEP
$69.9B
$127K ﹤0.01%
1,500
EBIZ icon
3706
Global X E-commerce ETF
EBIZ
$29.1M
$127K ﹤0.01%
3,707
NDLS icon
3707
Noodles & Co
NDLS
$111M
$127K ﹤0.01%
1,275
-1,990
-61% -$185K
BPMP
3708
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$127K ﹤0.01%
8,775
-972
-10% -$13.5K
PHAS
3709
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$126K ﹤0.01%
33,770
+21,016
+165% +$70K
AQST icon
3710
Aquestive Therapeutics
AQST
$476M
$125K ﹤0.01%
31,382
+14,770
+89% +$59K
CIEN icon
3711
PUT
Ciena
CIEN
$55.3B
$125K ﹤0.01%
2,200
IOO icon
3712
iShares Global 100 ETF
IOO
$9.05B
$125K ﹤0.01%
+1,755
New +$122K
KALA icon
3713
KALA BIO
KALA
$14.6M
$125K ﹤0.01%
10
-14
-58% -$220K
AMRX icon
3714
Amneal Pharmaceuticals
AMRX
$6.02B
$124K ﹤0.01%
24,455
-94,713
-79% -$538K
BBD icon
3715
PUT
Banco Bradesco
BBD
$39.4B
$124K ﹤0.01%
26,620
BBH icon
3716
VanEck Biotech ETF
BBH
$398M
$124K ﹤0.01%
+613
New +$114K
BSBR icon
3717
Santander
BSBR
$43B
$124K ﹤0.01%
15,810
-76,953
-83% -$572K
FCT
3718
First Trust Senior Floating Rate Income Fund II
FCT
$250M
$124K ﹤0.01%
9,785
ROBO icon
3719
ROBO Global Robotics & Automation Index ETF
ROBO
$2.02B
$124K ﹤0.01%
1,902
INVE icon
3720
Identive
INVE
$64.8M
$123K ﹤0.01%
7,277
-5,820
-44% -$87.9K
NGM
3721
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$123K ﹤0.01%
6,202
-20,367
-77% -$477K
ATEN icon
3722
A10 Networks
ATEN
$2.16B
$122K ﹤0.01%
10,727
-43,148
-80% -$418K
KALV
3723
DELISTED
KalVista Pharmaceuticals
KALV
$122K ﹤0.01%
5,069
-28,214
-85% -$738K
KZR
3724
DELISTED
Kezar Life Sciences
KZR
$122K ﹤0.01%
2,239
-2,199
-50% -$125K
CCO icon
3725
Clear Channel Outdoor Holdings
CCO
$1.23B
$121K ﹤0.01%
45,954
-492,013
-91% -$1.18M

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.